IOVANCE BIOTHERAPEUTICS, INC. (IOVA) has 23 open-market insider trades by 8 insiders since 2018. The most active filer is Merrill A. McPeak, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Wayne P. Rothbaum | Dir | — | 5 | $165.8M | 2024-02-20 |
| Merrill A. McPeak | Dir | — | 7 | $3.0M | 2024-02-20 |
| Ryan D. Maynard | Dir | — | 2 | $554K | 2024-11-12 |
| Iain D. Dukes | Dir | — | 3 | $458K | 2024-02-20 |
| Michael Weiser | Dir | — | 1 | $121K | 2022-05-31 |
| Daniel Gordon Kirby | CCO | — | 1 | $55K | 2026-08-10 |
| Frederick G. Vogt | CEOCLO | — | 3 | $55K | 2026-09-08 |
| Raj K. Puri | — | — | 1 | $10K | 2026-09-08 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Daniel Gordon Kirby | CCO | Buy | $55K | 2025-06-05 |
| Raj K. Puri | Chief Regulatory Officer | Buy | $10K | 2025-05-23 |
| Frederick G. Vogt | Interim CEO & General Counsel | Buy | $42K | 2025-05-14 |
| Ryan D. Maynard | Director | Sell | $503K | 2024-11-12 |
| Wayne P. Rothbaum | Director | Buy | $45.8M | 2024-02-20 |
| Merrill A. McPeak | Director | Buy | $2.3M |
Companies that share insiders with IOVA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2024-02-20 |
| Iain D. Dukes | Director | Buy | $293K | 2024-02-20 |
| Merrill A. McPeak | Director | Buy | $111K | 2023-09-18 |
| Wayne P. Rothbaum | Director | Buy | $26.5M | 2023-09-15 |
| Merrill A. McPeak | Director | Buy | $62K | 2022-12-21 |
| Wayne P. Rothbaum | Director | Buy | $65.0M | 2022-12-02 |
| Merrill A. McPeak | Director | Buy | $126K | 2022-11-29 |
| Merrill A. McPeak | Director | Buy | $62K | 2022-11-28 |
| Frederick G. Vogt | Interim CEO & General Counsel | Buy | $6K | 2022-11-28 |
| Iain D. Dukes | Director | Buy | $61K | 2022-11-23 |